Invention Grant
- Patent Title: Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders
- Patent Title (中): 使用EPO衍生的肽片段治疗神经变性疾病
-
Application No.: US13792336Application Date: 2013-03-11
-
Publication No.: US09585932B2Publication Date: 2017-03-07
- Inventor: Wei Lu , Peter C. Dowling , Rui Rong Yuan
- Applicant: Peter C. Dowling
- Applicant Address: US NJ Fort Lee
- Assignee: Peter C. Dowling
- Current Assignee: Peter C. Dowling
- Current Assignee Address: US NJ Fort Lee
- Agency: Locke Lord LLP
- Agent Bryan D. Zerhusen
- Main IPC: A61K38/00
- IPC: A61K38/00 ; C07K14/505 ; A61K38/10 ; A61K38/18
Abstract:
The described invention provides methods and kits for administering an EPO-derived peptide to a subject suffering from a neurodegenerative disease. The EPO-derived peptide delays the onset and/or progression of a neurodegenerative disease, limits cognitive impairment in, and prolongs the survival of, subjects suffering from a neurodegenerative disease.
Public/Granted literature
- US20160271206A9 USE OF EPO-DERIVED PEPTIDE FRAGMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Public/Granted day:2016-09-22
Information query
IPC分类:
